Imatinib for the treatment of rheumatic diseases
- PMID: 17396105
- DOI: 10.1038/ncprheum0465
Imatinib for the treatment of rheumatic diseases
Similar articles
-
Imatinib mesylate: an innovation in treatment of autoimmune diseases.Recent Pat Inflamm Allergy Drug Discov. 2013 Sep;7(3):259-67. doi: 10.2174/1872213x113079990021. Recent Pat Inflamm Allergy Drug Discov. 2013. PMID: 23947692 Review.
-
[Imatinib mesylate as a novel therapeutic drug for systemic rheumatic diseases].Nihon Rinsho Meneki Gakkai Kaishi. 2007 Jun;30(3):165-73. doi: 10.2177/jsci.30.165. Nihon Rinsho Meneki Gakkai Kaishi. 2007. PMID: 17603257 Review. Japanese.
-
Imatinib does not impair gonadal function.Leuk Res. 2012 Mar;36(3):262-3. doi: 10.1016/j.leukres.2011.11.003. Epub 2011 Nov 30. Leuk Res. 2012. PMID: 22129479 No abstract available.
-
Imatinib treatment of generalized localized scleroderma (morphea).J Am Acad Dermatol. 2010 Nov;63(5):e102-4. doi: 10.1016/j.jaad.2010.02.030. J Am Acad Dermatol. 2010. PMID: 20950732 No abstract available.
-
Is there a role for imatinib in inflammatory bowel disease?Inflamm Bowel Dis. 2008 Apr;14(4):579-81. doi: 10.1002/ibd.20320. Inflamm Bowel Dis. 2008. PMID: 18050299 No abstract available.
Cited by
-
PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.Pulm Circ. 2014 Mar;4(1):82-102. doi: 10.1086/674881. Pulm Circ. 2014. PMID: 25006424 Free PMC article.
-
Managing macrophages in rheumatoid arthritis by reform or removal.Curr Rheumatol Rep. 2012 Oct;14(5):445-54. doi: 10.1007/s11926-012-0272-4. Curr Rheumatol Rep. 2012. PMID: 22855296 Free PMC article. Review.
-
Transport mechanisms and their pathology-induced regulation govern tyrosine kinase inhibitor delivery in rheumatoid arthritis.PLoS One. 2012;7(12):e52247. doi: 10.1371/journal.pone.0052247. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284953 Free PMC article.
-
Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis.Iran J Pharm Res. 2021 Fall;20(4):33-46. doi: 10.22037/ijpr.2021.115481.15394. Iran J Pharm Res. 2021. PMID: 35194426 Free PMC article.
-
Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.Circ Res. 2020 Sep 11;127(7):855-873. doi: 10.1161/CIRCRESAHA.120.316951. Epub 2020 Jun 29. Circ Res. 2020. PMID: 32597702 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources